Rajaraman Krishnan

Senior Director, Neurosciences at Immuneering

Dr. Krishnan has expertise in understanding cellular responses to protein misfolding events and developing therapies to mitigate toxicity associated with these conditions. Over the last decade he was involved in designing Ig-fusion-based therapeutics to treat Alzheimer’s disease and Systemic Amyloidosis. Prior to joining the biotech industry, he conducted his postdoctoral research at the Whitehead Institute of Biomedical Research (MIT) and earned a PhD in Biophysics and Molecular Biology from the Center for Cellular and Molecular Biology, Hyderabad, India.


  • Senior Director, Neurosciences

    Current role

  • Head of Neuroscience Discovery

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.